ELI LILLY & CO (LLY:NYSE)
$1122.5 -6.85 (-0.6065%)
Analysed ELI LILLY & CO (LLY:NYSE) News Sources
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
16-06-2026
yahoo.com
Eli Lilly (LLY) Buys 4E Therapeutics As Jaypirca Hits Key Leukemia Milestone
16-06-2026
yahoo.com
European Stocks Higher in Tuesday Trading; Markets Buoyed by US, Iran Peace Deal; Inflation Remains a Concern
16-06-2026
yahoo.com
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
16-06-2026
fool.com
Sector Update: Healthcare Stocks Advance in Afternoon Trading
16-06-2026
yahoo.com
Eli Lilly’s hottest drugs face a quiet new threat
16-06-2026
thestreet.com
Novo Nordisk to File Oral Wegovy in China
16-06-2026
yahoo.com
Can Retatrutide Extend Eli Lilly and Co (LLY)’s Lead in Weight Loss Market?
16-06-2026
yahoo.com
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
16-06-2026
yahoo.com
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
16-06-2026
yahoo.com
What is the current price of ELI LILLY & CO (LLY:NYSE)?
The current price of ELI LILLY & CO (LLY:NYSE) is $1122.5.
ELI LILLY & CO (LLY:NYSE) absolute price change since previous trading day?
The absolute price change of ELI LILLY & CO (LLY:NYSE) since the previous trading day is $-6.85.
ELI LILLY & CO (LLY:NYSE) percentage price change since previous trading day?
The percentage price change of ELI LILLY & CO (LLY:NYSE) since the previous trading day is -0.6065%.
What is the most recent average sentiment score for ELI LILLY & CO (LLY:NYSE)?
The most recent average sentiment score for ELI LILLY & CO (LLY:NYSE) is 50 out of 100.
What is the most recent average sentiment for ELI LILLY & CO (LLY:NYSE)?
The most recent sentiment for ELI LILLY & CO (LLY:NYSE) is .
SEC-8K** Filing Available For ELI LILLY & CO (LLY:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.